Figure 3 | Scientific Reports

Figure 3

From: The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients

Figure 3

Long-term survival based on the tumor burden evaluation time point. (A, B) The OS and EFS, respectively, of patients who underwent bone marrow evaluations before and after interim therapy. (C, D) Correlations between OS or EFS and the tumor burden evaluated before FC treatment. (E, F) Correlations between OS or EFS and the tumor burden evaluated after FC treatment.

Back to article page